Harmonizing Strategic Partnerships & Patient-Centric Biomarker & Drug-Diagnostic Strategies with Regulatory Expectations to Streamline Access to Safer, More Efficacious Precision Therapeutics
Driven by advancements in genomic profiling, omics, and AI technologies, the biomarkers and diagnostics field continues to surge, with Roche and AstraZeneca’s world-first digital pathology CDx approval in April taking the number of approved CDx tests to a record high of 188.
We are now witnessing a need for new, stronger co-development partnerships to validate novel biomarkers, navigate global in vitro diagnostic regulation, and harmonize commercialization; which will in turn accelerate adoption of these drug-diagnostics across diverse therapeutic areas and markets.
Returning for its 15th anniversary this September, the World Clinical Biomarkers & Companion Diagnostics Summit will unite 600+ industry leaders across biopharma, CDx developers, testing labs, regulators, and payers to advance clinical biomarker strategies and accelerate drug-diagnostics to market for improved patient diagnosis, stratification, and monitoring.
Join us in celebrating 15 years of progress and be a part of the conversations and collaborations to define the next 15.
This forum is an industry targeted event with a very specific focus, I appreciate that this has stayed consistent for the precision medicine community over the years.
Global Director, AmgenÂ
A great opportunity to network with professionals in the companion diagnostics field and stay updated on the latest trends, emerging technologies and regulatory challenges.
Director, Translational Medicine, AstraZeneca
This forum forges the opportunity to 1) meet diverse group of individuals and organizations working in the CDx space 2) hear about ongoing efforts, challenges and wins, 3) meet key vendors working in the biomarker and CDx space.
Head of Translational Medicine, Pfizer
Explore the Full Event Guide
- Free* to Attend for Biopharma & Academia
- The World's Leading Biomarker & Drug-Diagnostic Forum
- Co-Development & Partnership Selection Panels
- Oncology, Neurological, Chronic, Autoimmune, & Rare Disease Biomarker Strategies
- Case studies on Genomic, Omic, Pathology, Flow Cytometry, & Cell Sequencing IVDs
- Exclusive Networking & Partnerships Opportunities
Expertise Partners Include
Attending Companies Include
Explore Related Events
Explore the Agenda
Hear the latest translational, clinical and post-approval breakthroughs and gain exclusive insights into precision medicine innovations during our packed agenda, interactive roundtables, and new drug-diagnostic partnerships panel discussions
Partner With Us
Position yourself alongside other leading IVD and CDx solution providers to ensure your brand is at the heart of precision medicines deals and collaborations
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning a range of precision therapy modalities and indications, and make critical connections during our dedicated networking sessions